| 18322385 |
Wolozin B, Saha S, Guillily M, Ferree A, Riley M: Investigating convergent actions of genes linked to familial Parkinson's disease. Neurodegener Dis. 2008;5(3-4):182-5. Epub 2008 Mar 6.
BACKGROUND: Mutations in LRRK2 are among the most frequent genetic changes identified in Parkinson's disease (PD), but how LRRK2 contributes to the pathophysiology of PD is not known. OBJECTIVES: To investigate how expressing wild-type or G2019S LRRK2 modifies cellular responses to rotenone, a mitochondrial toxin. METHODS: We investigated the vulnerability to mitochondrial toxins in Caenorhabditis elegans expressing wild-type or G2019S LRRK2. RESULTS: We observed a powerful role for LRRK2 in mitochondrial biology. Overexpressing LRRK2 strongly protects C. elegans against rotenone toxicity. The G2019S LRRK2 construct also protected LRRK2 against rotenone, but to a lesser degree than wild-type LRRK2. Knockdown of lrk-1 potentiated rotenone toxicity. CONCLUSIONS: These data suggest that LRRK1/2 regulate mitochondrial physiology. |
95(1,1,3,5) |